Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complementary peptides that interfere with platelet aggregation and adherence

T K Gartner1, D B Taylor, J Derrick

  • 1Department of Biology, University of Memphis, Tennessee 38152.

Immunomethods
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical outcomes after radioactive 125I seed versus hookwire localization of non-palpable breast cancer: a multicentre randomized clinical trial.

The British journal of surgery·2021
Same author

Cost-effectiveness of radioguided occult lesion localization using 125I seeds versus hookwire localization before breast-conserving surgery for non-palpable breast cancer.

The British journal of surgery·2021
Same author

Non-mass versus mass-like ultrasound patterns in ductal carcinoma in situ: is there an association with high-risk histology?

Clinical radiology·2019
Same author

Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.

Clinical radiology·2017
Same author

Analysing breast tissue composition with MRI using currently available short, simple sequences.

Clinical radiology·2016
Same author

Behavioural responses of stable flies to cattle manure slurry associated odourants.

Medical and veterinary entomology·2015
Same journal

Generation of Human Monoclonal Autoantibody-Producing Cell Lines by Epstein-Barr Virus Transformation of Autoreactive B Lymphocytes and by Somatic Cell Hybridization Techniques: Application to the Analysis of the Autoimmune B Cell Repertoire.

ImmunoMethods·2016
Same journal

Immunologically based methods for the elimination of tumor cells from autologous stem cell grafts.

ImmunoMethods·1994
Same journal

Detection of minimal residual disease in autologous grafts.

ImmunoMethods·1994
Same journal

Peripheral blood progenitor cell transplantation for hematological malignancies.

ImmunoMethods·1994
Same journal

Genetic marking and manipulation of hematopoietic progenitor cells using retroviral vectors.

ImmunoMethods·1994
Same journal

T-cell depletion and manipulation in allogeneic hematopoietic cell transplantation.

ImmunoMethods·1994
See all related articles

Researchers designed peptides to inhibit fibrinogen binding to platelets, potentially preventing thrombosis. These peptides offer insights into platelet function and may lead to new anti-thrombotic therapies.

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Fibrinogen binding to platelets is crucial for thrombosis.
  • Understanding this interaction is key for developing anti-thrombotic agents.

Purpose of the Study:

  • To design and synthesize peptides inhibiting fibrinogen-platelet interactions.
  • To validate the molecular recognition hypothesis for peptide design.
  • To investigate fibrinogen's binding site on platelets.

Main Methods:

  • Peptide design and synthesis based on molecular recognition principles.
  • Characterization of peptide efficacy in inhibiting platelet aggregation, adhesion, and clot retraction.
  • Studies aimed at identifying the platelet fibrinogen receptor binding site.

Related Experiment Videos

Main Results:

  • Successful design and synthesis of peptides inhibiting fibrinogen binding to platelets.
  • Demonstrated inhibition of platelet aggregation, adhesion, and clot retraction.
  • Identified peptides that may be platelet-specific, though not ligand-specific.

Conclusions:

  • The molecular recognition hypothesis provides a valid rationale for designing anti-platelet peptides.
  • Developed peptides show potential for inhibiting thrombosis by blocking fibrinogen binding.
  • Further research may yield clinically useful anti-thrombotic drugs.